The vision at the Asthma Society of Canada is to empower every child and adult in Canada with asthma to live an active and symptom-free life.
For close to 25 years, the Asthma Society of Canada has been a leader in asthma care. They're the experts. They are dedicated to helping Canadians live with asthma through research and education.
Education and awareness is the key to helping Canadians achieve symptom-free asthma and the Asthma Society of Canada takes this seriously.
assets
This animation illustrates the pattern of inflammation characteristic of asthma, involving several inflammatory cells and multiple mediators that result in pathophysiological changes.
Mechanism of Asthma
Inhaled glucocorticosteroids are currently the most effective anti-inflammatory medications for the treatment of persistent asthma.
Glucocorticosteroids
Leukotriene modifiers have a small and variable bronchodilator effect, reduce symptoms including cough, improve lung function, and reduce airway inflammation and asthma exacerbations.
Leukotriene Modifiers
For patients with severe allergic asthma who are uncontrolled on inhaled glucocorticosteriods, Anti-IgE therapy may be an option in the context of elevated serum levels of IgE.
Anti-IgE
Most effective when combined with inhaled glucocorticosteroids, this combination therapy is the preferred treatment when a medium dose of inhaled glucocorticosteroid alone fails to achieve asthma control.
Long-acting Inhaled ß2-Agonists
Rapid-acting inhaled ß2-agonists are the medications of choice for relief of bronchocontriction and for the pretreatment of exercise-induced bronchoconstriction.
Rapid-acting Inhaled ß2-Agonists
The inflammatory aspect of asthma and the role of reliever and controller therapies in establishing asthma control are depicted in this animation, to aid the patient in understanding the importance of symptom monitoring and medication adherence.
Changing Your Asthma Story